Tizanidine Hydrochloride Capsule
Product Images NDC 76420-902

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tizanidine Hydrochloride (NDC 76420-902). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Asclemed Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tiz01 (Tiz01)

Chemical structure of Tizanidine Hydrochloride, showing its molecular framework including a chlorinated aromatic ring linked to an imidazoline and a thiazole ring.*

FDA Label Image

Tiz02 (Tiz02)

A line graph depicting plasma tizanidine concentration (ng/mL) over time (hours) following dosing. Four curves compare 4 mg tizanidine tablets and capsules administered with and without food, illustrating the pharmacokinetic profiles up to 24 hours post-dose.*

FDA Label Image

Tiz03 (Tiz03)

A line graph showing improvement in Ashworth Score over 6 hours post-dose comparing 16 mg tizanidine, 8 mg tizanidine, and placebo. The x-axis represents hours post-dose, and the y-axis represents improvement score. Both tizanidine doses show increased improvement versus placebo, with 16 mg showing the greatest effect around 2 hours.*

FDA Label Image

Tiz04 (Tiz04)

A line graph showing improvement in Ashworth Score over time at three points: End of Titration (Week 3), End of Maintenance (Week 7), and Endpoint (Last Observation Carried Forward). The graph compares tizanidine (mean dose 28.8 mg), represented by squares, and placebo, represented by circles. Error bars indicate variability in the measurements, with tizanidine showing consistent improvement and placebo showing minimal change.*

FDA Label Image

Label (Tizanidine Hydrochloride 2mg)

Labels for Tizanidine Hydrochloride Capsules 2 mg from Enovachem Pharmaceuticals and relabeled by them, showing multiple packaging sizes including 10, 20, 30, 60, and 90 capsules. The labels include NDC numbers, a description of the capsules as light blue opaque, distributor Ascend Laboratories LLC, storage information, and federal dispensing warnings.*

FDA Label Image

Label (Tizanidine Hydrochloride 4mg)

This image shows multiple packaging labels for Tizanidine Hydrochloride Capsules 4 mg in various quantities including 10, 20, 30, 60, 90, 150, and 500 capsules. The labels indicate the product is packaged and relabeled by Enovachem Pharmaceuticals, distributed by Ascend Laboratories, LLC, and feature barcodes and NDC numbers for each package size. The capsules are described as blue opaque capsules containing 4 mg of Tizanidine Hydrochloride.*

FDA Label Image

Label (Tizanidine Hydrochloride 6mg)

Labels for Tizanidine Hydrochloride Capsules 6 mg, packaged or relabeled by Enovachem Pharmaceuticals. The labels show various package quantities including 10, 20, 30, 60, 90, 150, and 500 capsules. The labels include NDC numbers, barcodes, and caution statements about prescription and storage. Distributed by Ascend Laboratories, LLC, with a blue opaque capsule description.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.